The present invention relates to compounds which have agonist activity at the glucagon, GIP and GLP-1 receptors, and to their use in the treatment of metabolic disorders.
申请公布号
EP3066117(A1)
申请公布日期
2016.09.14
申请号
EP20140805199
申请日期
2014.11.06
申请人
ZEALAND PHARMA A/S
发明人
JUST, RASMUS;RIBER, DITTE;SHELTON, ANNE PERNILLE TOFTENG;ØSTERLUND, TORBEN;HANSEN, KATE;JESSEN, LENE
